SRIN Therapeutics is advancing novel treatment options for patients by harnessing the power of the endocannabinoid system. The company focuses on biotechnology and pharmaceuticals.
Kannalife Sciences, IncFounded in 2010 and based at the Pennsylvania Biotechnology Center in Doylestown, Kannalife Sciences develops patented synthetic CBD-inspired therapeutics for neuroinflammation, neuropathic pain and neurodegenerative disease. Its lead investigational molecule, KLS-13019, is being advanced as a potential non-opioid treatment for chemotherapy-induced peripheral neuropathy, with research also examining Parkinson’s disease and other conditions linked to oxidative stress. Kannalife is a wholly owned Neuropathix subsidiary whose scientific team reports more than 75 years of combined pharmaceutical research experience and over 65 jointly held patents.DOYLESTOWN, PA
ResilienceNational Resilience, Inc. is a technology-focused biomanufacturing company founded in 2020 to broaden access to complex medicines and strengthen biopharmaceutical supply chains. It operates an end-to-end manufacturing network across North America, supporting development and production of medicines from early phase through commercial manufacturing. Its facilities produce drug substances and drug products, including cell therapies and vaccines.BLUE ASH, OH
Neuropathix, IncFounded in 2010 through the creation of Kannalife Sciences, Neuropathix develops synthetic CBD-inspired therapeutics for neuroinflammation, neuropathic pain and neurodegenerative disease. Its lead compound, KLS-13019, is a globally patented non-opioid candidate being advanced from preclinical and IND-enabling research for chemotherapy-induced peripheral neuropathy, with research conducted at the Pennsylvania Biotechnology Center in Doylestown. The company’s scientific team brings more than 75 years of pharmaceutical research experience and holds more than 65 patents jointly.DOYLESTOWN, PA
TerSera Therapeutics LLCFounded in 2016, TerSera Therapeutics is a biopharmaceutical company that develops, commercializes, and supports medicines aimed at unmet patient needs. Based in Deerfield, the company combines clinical development expertise with a patient-focused approach and maintains a portfolio spanning oncology, rare disease, and non-opioid pain. Its support programs help patients and providers navigate access and treatment.DEERFIELD, IL